Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan

Der Yuan Chen, Ping Ning Hsu, Chao Hsiun Tang, Lindsay Claxton, Satish Valluri, Robert A. Gerber

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences